← Leaderboards
Kelvin P Lee
University Of Miami School Of Medicine
$20,240,939
Attributed
$21,290,025
Total exposure
15
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,661,948 · 16
By mechanism
P30$20,323,313 · 7
R01$11,971,734 · 5
C06$4,675,896 · 1
T32$1,487,959 · 1
R24$825,403 · 1
R21$377,643 · 1
Top collaborators
- Scott Henry Olejniczak3 shared
- Manel Jordana2 shared
Others in their field
Top investigators on “Multiple Myeloma”
- David Heimbrook · Leidos Biomedical Research, Inc.$146,380,351
- Larry Arthur$41,717,333
- Charles A Coltman · Southwest Oncology Group$36,988,659
- Kenneth C Anderson · Dana-Farber Cancer Inst$25,497,347
- Irene M. Ghobrial · Dana-Farber Cancer Inst$22,402,686
- Nilsa Del Carmen Ramirez · Ohio State University$22,287,552
Research focus
Multiple MyelomaCessation Of LifePlayFundingClinical ResearchPlasma CellsBone MarrowCell SurvivalT-LymphocyteCellsCd28 GeneMalignant NeoplasmsResistanceHematologic NeoplasmsRegulationReceptorCd80 GeneBiologyMolecularDisease ProgressionDendritic CellsDrug ResistanceSignal TransductionPrograms
Grant awards (71)
Indiana University Melvin and Bren Simon Comprehensive Cancer Center Support Grant$2,845,630
P30 · FY2025 · CA · contact PI
Novel pro-survival mechanisms of PIM2 in multiple myeloma$571,063
R01 · FY2025 · CA · contact PI
Leadership, Planning an Evaluation$534,647
P30 · FY2025 · CA · contact PI
Indiana University Melvin and Bren Simon Comprehensive Cancer Center Support Grant$2,845,630
P30 · FY2024 · CA · contact PI
Novel pro-survival mechanisms of PIM2 in multiple myeloma$552,872
R01 · FY2024 · CA · contact PI
GAIPO: graph artificial intelligence for pediatric oncology$498,601
P30 · FY2024 · CA · contact PI
Indiana University Melvin and Bren Simon Cancer Center Support Grant$2,746,580
P30 · FY2023 · CA · contact PI
Novel pro-survival mechanisms of PIM2 in multiple myeloma$596,594
R01 · FY2023 · CA · contact PI
Leadership, Planning, and Evaluation$501,296
P30 · FY2023 · CA · contact PI
CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival$335,089
R01 · FY2023 · CA · contact PI
Cancer Center Administration$199,087
P30 · FY2023 · CA · contact PI
Indiana University Melvin and Bren Simon Cancer Center Support Grant$2,746,580
P30 · FY2022 · CA · contact PI
CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival$318,046
R01 · FY2022 · CA · contact PI
Indiana University Melvin and Bren Simon Cancer Center Support Grant$2,746,580
P30 · FY2021 · CA · contact PI
The Big Ten Electronic Health Record Consortium (Big Ten-EHRC)$499,058
P30 · FY2021 · CA · contact PI
CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival$195,504
R01 · FY2021 · CA · contact PI
CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival$172,309
R01 · FY2021 · CA · contact PI
Indiana University Melvin and Bren Simon Cancer Center Support Grant$2,746,580
P30 · FY2020 · CA · contact PI
Leadership, Planning, and Evaluation$501,296
P30 · FY2020 · CA · contact PI
The Big Ten Electronic Health Record Consortium (Big Ten-EHRC)$499,058
P30 · FY2020 · CA · contact PI
CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival$367,920
R01 · FY2020 · CA · contact PI
Indiana University Melvin and Bren Simon Cancer Center Support Grant$197,626
P30 · FY2020 · CA · contact PI
Tumor Immunology and Immunotherapy$45,965
P30 · FY2020 · CA · contact PI
CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival$385,757
R01 · FY2019 · CA · contact PI
Multidisciplinary Approaches to Tumor Immunology$89,786
T32 · FY2019 · CA · contact PI
Tumor Immunology and Immunotherapy$45,965
P30 · FY2019 · CA · contact PI
CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival$171,814
R01 · FY2018 · CA · contact PI
Multidisciplinary Approaches to Tumor Immunology$82,107
T32 · FY2018 · CA · contact PI
CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival$137,736
R01 · FY2017 · CA · contact PI
Multidisciplinary Approaches to Tumor Immunology$127,502
T32 · FY2017 · CA · contact PI
Durable humoral immunity regulated by intrinsic CD28 function in plasma cells$501,205
R01 · FY2016 · AI · contact PI
CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival$309,550
R01 · FY2016 · CA · contact PI
Multidisciplinary Approaches to Tumor Immunology$128,156
T32 · FY2016 · CA · contact PI
Durable humoral immunity regulated by intrinsic CD28 function in plasma cells$508,933
R01 · FY2015 · AI · contact PI
CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival$309,550
R01 · FY2015 · CA · contact PI
Multidisciplinary Approaches to Tumor Immunology$131,663
T32 · FY2015 · CA · contact PI
Durable humoral immunity regulated by intrinsic CD28 function in plasma cells$516,435
R01 · FY2014 · AI · contact PI
CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival$300,263
R01 · FY2014 · CA · contact PI
Overcoming established anaphylactic hypersensitivity to peanuts$214,505
R21 · FY2014 · AI · contact PI
Multidisciplinary Approaches to Tumor Immunology$155,380
T32 · FY2014 · CA · contact PI
Durable humoral immunity regulated by intrinsic CD28 function in plasma cells$492,294
R01 · FY2013 · AI · contact PI
CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival$327,000
R01 · FY2013 · CA · contact PI
Overcoming established anaphylactic hypersensitivity to peanuts$163,138
R21 · FY2013 · AI · contact PI
Multidisciplinary Approaches to Tumor Immunology$151,963
T32 · FY2013 · CA · contact PI
CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival$294,191
R01 · FY2011 · CA · contact PI
Multidisciplinary approaches to tumor immunology$133,450
T32 · FY2011 · CA · contact PI
Extramural Research Facility Construction Projects. Ros*$4,675,896
C06 · FY2010 · RR · contact PI
CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival$300,016
R01 · FY2010 · CA · contact PI
Multidisciplinary approaches to tumor immunology$139,198
T32 · FY2010 · CA · contact PI
CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival$296,838
R01 · FY2009 · CA · contact PI
Multidisciplinary approaches to tumor immunology$108,208
T32 · FY2009 · CA · contact PI
CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival$293,753
R01 · FY2008 · CA · contact PI
Multidisciplinary approaches to tumor immunology$132,711
T32 · FY2008 · CA · contact PI
Program Leaders$123,134
P30 · FY2008 · CA · contact PI
CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival$290,757
R01 · FY2007 · CA · contact PI
Multidisciplinary approaches to tumor immunology$107,835
T32 · FY2007 · CA · contact PI
Arsenic Trioxide & Ascorbic Acid for Multiple Myeloma$463,598
R01 · FY2006 · CA · contact PI
Human Hematopoietic and Immune Cell Bank$173,099
R24 · FY2006 · CA · contact PI
Arsenic Trioxide & Ascorbic Acid for Multiple Myeloma$68,467
R01 · FY2006 · CA · contact PI
Arsenic Trioxide &Ascorbic Acid for Multiple Myeloma$528,999
R01 · FY2005 · CA
Human Hematopoietic and Immune Cell Bank$160,743
R24 · FY2005 · CA
Arsenic Trioxide &Ascorbic Acid for Multiple Myeloma$513,593
R01 · FY2004 · CA
Human Hematopoietic and Immune Cell Bank$162,523
R24 · FY2004 · CA
Arsenic Trioxide &Ascorbic Acid for Multiple Myeloma$498,632
R01 · FY2003 · CA
INDUCED LEUKEMIC CELL DIFFERENTIATION TO DENDRITC CELL$223,548
R01 · FY2003 · CA
Human Hematopoietic and Immune Cell Bank$163,971
R24 · FY2003 · CA
Arsenic Trioxide &Ascorbic Acid for Multiple Myeloma$497,081
R01 · FY2002 · CA
INDUCED LEUKEMIC CELL DIFFERENTIATION TO DENDRITC CELL$217,037
R01 · FY2002 · CA
Human Hematopoietic and Immune Cell Bank$165,067
R24 · FY2002 · CA
INDUCED LEUKEMIC CELL DIFFERENTIATION TO DENDRITC CELL$210,714
R01 · FY2001 · CA
INDUCED LEUKEMIC CELL DIFFERENTIATION TO DENDRITC CELL$204,576
R01 · FY2000 · CA